Opdivo plus Yervoy in Mesothelioma cancer
Mesothelioma – New Approval of Drug Combination Treatment
Introduction On October 2nd 2020, the FDA approved Opdivo (Nivolumab) in combination with Yervoy (Ipilimumab) for the first-line treatment of patients with Malignant Pleural Mesothelioma that cannot be removed by…